Trxade Group Inc. (NASDAQ: MEDS) was featured in a recent equity research report published by Dougherty & Company LLC. The report reads, “We reiterate our Buy rating and $12 Price Target on MEDS following Q1 results that beat expectations. As the only estimate on the Street, we note that revenue, EBITDA and EPS were each … Continue reading “NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Featured in Dougherty & Company LLC Research Report”
Trxade Group, Inc. (NASDAQ: MEDS), an integrated telehealth, drug procurement, delivery and online healthcare marketplace, today reported its financial results for the first quarter ended March 31, 2020. Among the highlights, Trxade reported a 46% increase in Q1 2020 revenues to $2.2 million and 44% increase in net income to $0.2 million. “We demonstrated outstanding … Continue reading “NetworkNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Releases Q1 2020 Financial Results”
Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, was featured in an exclusive NetworkNewsWire (“NNW”) audio podcast, via NNW’s audio press release solutions suite. The podcast contains NNW editorial coverage titled, “Medical Supply Companies Take on Crucial Role in Combatting Coronavirus” (http://nnw.fm/pmzJ6.) Among other companies providing different critical elements in … Continue reading “NetworkNewsBreaks – Trxade Group, Inc.’s (NASDAQ: MEDS) Integral Role in Efforts to Combat COVID-19 Featured in NetworkNewsAudio Podcast”
Trxade Group (NASDAQ: MEDS) was featured in a recent equity research report published by Dougherty & Company LLC. The report reads, “We are initiating coverage of Trxade with a Buy rating and Price Target of $12. MEDS’ primary offering is a web-based platform connecting large suppliers of branded and generic drugs with retail and independent … Continue reading “NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Featured in Dougherty & Company LLC Research Report”
Related Editorial With COVID-19 ravaging the world, medical supply companies quickly became critically important. Different companies provide different critical elements in the sad saga unfolding in this pandemic. Trxade Group Inc. (NASDAQ: MEDS) (MEDS Profile) provides a technology platform to obtain essential resources to corner pharmacies across the entire nation, delivering products and facilitating services … Continue reading “NetworkNewsAudio – Trxade Group Inc. (NASDAQ: MEDS) Delivering Products, Facilitating Services to Help Combat COVID-19”
Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced its engagement of international investor relations specialists MZ Group (“MZ”) to expand its comprehensive strategic investor relations and financial communications program across all key markets. According to the update, MZ Group will work closely with Trxade Group management in the … Continue reading “NetworkNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces Engagement of MZ Group to Expand Strategic Communications Program Across Key Markets”
Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced entry into its first Covid-19 antibody testing kits supply agreement with law firm McIntyre Thanasides Bringgold Elliott Grimaldi Guito & Matthews, P.A. According to the update, the midsized Tampa firm will today begin periodic testing of its employees and their … Continue reading “NetworkNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Enters First Agreement to Supply COVID-19 Testing Kits”
Trxade Group’s (NASDAQ: MEDS) wholly owned subsidiary Bonum Health is a virtual telehealth provider that is helping patients to simply and affordably access board-certified physicians and receive medical prescriptions from the comfort of their homes. A recent article discussing the company reads, “On March 4, 2020, Congress approved an $8.3 billion package (http://nnw.fm/8qDeg) in emergency … Continue reading “NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Subsidiary Enabling Patients to Access Physicians from Home”
Company boasts significant first-mover advantage in proprietary web-based e-commerce platform segment Revenue growth driven by increases in the number of registered users and acquisition of Pharmacy Currently adding 100+ pharmacies per month to its online purchasing platform Trxade seeking FDA approval for antibody rapid test that can be used for COVID-19 patients Trxade Group Inc. … Continue reading “Trxade Group Inc.’s (NASDAQ: MEDS) E-Commerce Platform Targeting Independent Pharmacy Market of Over $78 Billion a Year”
Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, has more than 12,100 pharmacies currently registered as users of its proprietary Supplier-to-Pharmacy (“S2P”) e-commerce platform. An article discussing the company reads, “With the current number of users already … Continue reading “NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Reaches Thousands of Independent Pharmacies with e-Commerce Platform”
